How it all began
Harald Schnidar started the company in 2014 while he was conducting a dermatological clinical trial. He was developing a skin drug to treat severe radiation burns, and he noticed that physicians were only able to perform subjective skin assessments, which was the standard at the time. He saw a need for upgraded technology: “Based on [trial] data, I developed a first skin imaging algorithm, which is after some years now clinically proven, which lead me to develop the Scarletred Vision technology. At that time point, there was no technology in the market, which allows to objectify dermatological assessment. And what Scarletred does is we quantify and allow to quantify skin images by introducing with a mobile app calibration method.”
Read the full story about SCARLETRED here
In the previous five years we have:
… won 11 awards
… produced 1,5 million Scarletred®Vision skin patches
… 500 users from industry
… finished 50 clinical studies
… purchased 20 pairs of (scarlet)red sneakers
… decorated our office with all 128 shades of red (come visit us and see for yourself)
Future plans
Over the last years we grew from a startup to an international company. We successfully finished a recent study with L’Oréal in Brazil, acquired a new client in the United Kingdom with 25 hospitals involved and we are about to start a new cooperation with SeneCura, the leading operator of nursing homes in Central Europe. A lot more exciting projects with leading companies will be announced over the next months. Stay tuned!
Stay connected
Schedule an online live demo here
Follow SCARLETRED also via:
LinkedIn
Twitter
Instagram
Facebook